Villalpando-Rodriguez confirmed combined use of siramesine and lapatinib could induce ferroptosis in lung cancer cells by inhibiting heme oxygenase-1 (HO-1) expression (Villalpando-Rodriguez et al., 2019). The gene discussed is HMOX1; the disease is lung carcinoma.